These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
700 related articles for article (PubMed ID: 9462663)
1. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy. Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663 [TBL] [Abstract][Full Text] [Related]
2. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas. Nakatsukasa H; Ashida K; Higashi T; Ohguchi S; Tsuboi S; Hino N; Nouso K; Urabe Y; Kinugasa N; Yoshida K; Uematsu S; Ishizaki M; Kobayashi Y; Tsuji T Hepatology; 1996 Jul; 24(1):82-8. PubMed ID: 8707287 [TBL] [Abstract][Full Text] [Related]
3. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma. Niwa Y; Matsumura M; Shiratori Y; Imamura M; Kato N; Shiina S; Okudaira T; Ikeda Y; Inoue T; Omata M Hepatology; 1996 Jun; 23(6):1384-92. PubMed ID: 8675155 [TBL] [Abstract][Full Text] [Related]
4. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma. Fujioka M; Nakashima Y; Nakashima O; Kojiro M Hepatology; 2001 Dec; 34(6):1128-34. PubMed ID: 11732002 [TBL] [Abstract][Full Text] [Related]
5. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma. Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339 [TBL] [Abstract][Full Text] [Related]
6. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637 [TBL] [Abstract][Full Text] [Related]
7. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences. Arbuthnot P; Bralet MP; Thomassin H; Danan JL; Bréchot C; Ferry N Hepatology; 1995 Dec; 22(6):1788-96. PubMed ID: 7489990 [TBL] [Abstract][Full Text] [Related]
8. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. Hsu HC; Cheng W; Lai PL Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521 [TBL] [Abstract][Full Text] [Related]
9. The targeted expression of interleukin-2 in human hepatocellular carcinoma cells. He P; Tang ZY; Ye SL; Liu BB; Liu YK J Exp Clin Cancer Res; 2000 Jun; 19(2):183-7. PubMed ID: 10965816 [TBL] [Abstract][Full Text] [Related]
10. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter. Cai X; Zhou J; Chang Y; Sun X; Li P; Lin J Cancer Lett; 2008 Jun; 264(1):71-82. PubMed ID: 18407409 [TBL] [Abstract][Full Text] [Related]
11. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter. Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430 [TBL] [Abstract][Full Text] [Related]
12. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Wong IH; Lau WY; Leung T; Yeo W; Johnson PJ Clin Cancer Res; 1999 Dec; 5(12):4021-7. PubMed ID: 10632334 [TBL] [Abstract][Full Text] [Related]
13. Distribution of albumin- and/or alpha-fetoprotein-positive cells in hepatocellular carcinoma. Kojiro M; Kawano Y; Isomura T; Nakashima T Lab Invest; 1981 Mar; 44(3):221-6. PubMed ID: 6162058 [TBL] [Abstract][Full Text] [Related]
14. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma. Guo XZ; Friess H; Di Mola FF; Heinicke JM; Abou-Shady M; Graber HU; Baer HU; Zimmermann A; Korc M; Büchler MW Hepatology; 1998 Dec; 28(6):1481-8. PubMed ID: 9828210 [TBL] [Abstract][Full Text] [Related]
15. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China. Dong-Dong L; Xi-Ran Z Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194 [TBL] [Abstract][Full Text] [Related]
16. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma. Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540 [TBL] [Abstract][Full Text] [Related]
17. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143 [TBL] [Abstract][Full Text] [Related]
18. [AFP gene expression and antigenic protein localization in the cells of hepatocellular carcinoma and its surrounding tissues]. Dai YM Zhonghua Yi Xue Za Zhi; 1989 Nov; 69(11):625-8, 44. PubMed ID: 2483982 [TBL] [Abstract][Full Text] [Related]
19. Regulatory regions of growth-related genes can activate an exogenous gene of the alpha-fetoprotein promoter to a comparable degree in human hepatocellular carcinoma cells. Tomizawa M; Saisho H; Tagawa M Anticancer Res; 2003; 23(4):3273-7. PubMed ID: 12926063 [TBL] [Abstract][Full Text] [Related]
20. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas. Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]